P53 Basic C Terminus Regulates P53 Functions Through DNA Binding Modulation of Subset of Target Genes

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Apr 20

PMID 22514277

Citations 25

Authors

Pierre-Jacques Hamard

Dana J Lukin

James J Manfredi

Affiliations

Soon will be listed here.

Abstract

The p53 gene encodes a transcription factor that is composed of several functional domains: the N-terminal transactivation domain, the central sequence-specific DNA binding domain, the tetramerization domain, and the highly basic C-terminal regulatory domain (CTD). The p53 CTD is a nonspecific DNA binding domain that is subject to extensive post-translational modifications. However, the functional significance of the p53 CTD remains unclear. The role of this domain in the regulation of p53 functions is explored by comparing the activity of ectopically expressed wild-type (WT) p53 protein to that of a truncated mutant lacking the 24 terminal amino acids (Δ24). Using quantitative real time PCR and chromatin Immuno-Precipitation experiments, a p53 CTD deletion is shown to alter the p53-dependent induction of a subset of its target genes due to impaired specific DNA binding. Moreover, p53-induced growth arrest and apoptosis both require an intact p53 CTD. These data indicate that the p53 CTD is a positive regulator of p53 tumor suppressor functions.

Citing Articles

How does p53 work? Regulation by the intrinsically disordered domains.

Dyson H, Wright P Trends Biochem Sci. 2024; 50(1):9-17.

PMID: 39578215 PMC: 11698644. DOI: 10.1016/j.tibs.2024.10.009.

Navigating the complexity of p53-DNA binding: implications for cancer therapy.

Thayer K, Stetson S, Caballero F, Chiu C, Han I Biophys Rev. 2024; 16(4):479-496.

PMID: 39309126 PMC: 11415564. DOI: 10.1007/s12551-024-01207-4.

Regulation of the p53‑mediated ferroptosis signaling pathway in cerebral ischemia stroke (Review).

Xu S, Li X, Wang Y Exp Ther Med. 2023; 25(3):113.

PMID: 36793330 PMC: 9922943. DOI: 10.3892/etm.2023.11812.

Mapping Interactions of the Intrinsically Disordered C-Terminal Regions of Tetrameric p53 by Segmental Isotope Labeling and NMR.

Krois A, Park S, Martinez-Yamout M, Dyson H, Wright P Biochemistry. 2022; 61(23):2709-2719.

PMID: 36380579 PMC: 9788666. DOI: 10.1021/acs.biochem.2c00528.

Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities.

Annor G, Elshabassy N, Lundine D, Conde D, Xiao G, Ellison V Front Cell Dev Biol. 2021; 9:772315.

PMID: 34881245 PMC: 8645790. DOI: 10.3389/fcell.2021.772315.

References

Kim H, Kim K, Choi J, Heo K, Baek H, Roeder R . p53 requires an intact C-terminal domain for DNA binding and transactivation. J Mol Biol. 2011; 415(5):843-54. PMC: 3267882. DOI: 10.1016/j.jmb.2011.12.001. View

Olsson A, Manzl C, Strasser A, Villunger A . How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?. Cell Death Differ. 2007; 14(9):1561-75. DOI: 10.1038/sj.cdd.4402196. View

Liu Y, Lagowski J, Vanderbeek G, Kulesz-Martin M . Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domain. Cancer Biol Ther. 2004; 3(11):1102-8. DOI: 10.4161/cbt.3.11.1189. View

Tafvizi A, Huang F, Fersht A, Mirny L, van Oijen A . A single-molecule characterization of p53 search on DNA. Proc Natl Acad Sci U S A. 2010; 108(2):563-8. PMC: 3021058. DOI: 10.1073/pnas.1016020107. View

Bourdon J . p53 and its isoforms in cancer. Br J Cancer. 2007; 97(3):277-82. PMC: 2360320. DOI: 10.1038/sj.bjc.6603886. View

Wang Y, Leblanc M, Fox N, Mao J, Tinkum K, Krummel K . Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev. 2011; 25(13):1426-38. PMC: 3134085. DOI: 10.1101/gad.2024411. View

Beckerman R, Prives C . Transcriptional regulation by p53. Cold Spring Harb Perspect Biol. 2010; 2(8):a000935. PMC: 2908772. DOI: 10.1101/cshperspect.a000935. View

Khoury M, Bourdon J . The isoforms of the p53 protein. Cold Spring Harb Perspect Biol. 2010; 2(3):a000927. PMC: 2829963. DOI: 10.1101/cshperspect.a000927. View

Bruins W, Bruning O, Jonker M, Zwart E, van der Hoeven T, Pennings J . The absence of Ser389 phosphorylation in p53 affects the basal gene expression level of many p53-dependent genes and alters the biphasic response to UV exposure in mouse embryonic fibroblasts. Mol Cell Biol. 2008; 28(6):1974-87. PMC: 2268391. DOI: 10.1128/MCB.01610-07. View

10.

Miyashita T, Reed J . Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995; 80(2):293-9. DOI: 10.1016/0092-8674(95)90412-3. View

11.

Ou Y, Chung P, Sun T, Shieh S . p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell. 2005; 16(4):1684-95. PMC: 1073652. DOI: 10.1091/mbc.e04-08-0689. View

12.

Flaman J, Waridel F, Estreicher A, Vannier A, Limacher J, Gilbert D . The human tumour suppressor gene p53 is alternatively spliced in normal cells. Oncogene. 1996; 12(4):813-8. View

13.

Yu J, Zhang L, Hwang P, Kinzler K, Vogelstein B . PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell. 2001; 7(3):673-82. DOI: 10.1016/s1097-2765(01)00213-1. View

14.

Armata H, Garlick D, Sluss H . The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. Cancer Res. 2007; 67(24):11696-703. DOI: 10.1158/0008-5472.CAN-07-1610. View

15.

Hupp T, Meek D, Midgley C, Lane D . Regulation of the specific DNA binding function of p53. Cell. 1992; 71(5):875-86. DOI: 10.1016/0092-8674(92)90562-q. View

16.

Chao C, Hergenhahn M, Kaeser M, Wu Z, Saito S, Iggo R . Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem. 2003; 278(42):41028-33. DOI: 10.1074/jbc.M306938200. View

17.

Harms K, Chen X . The C terminus of p53 family proteins is a cell fate determinant. Mol Cell Biol. 2005; 25(5):2014-30. PMC: 549381. DOI: 10.1128/MCB.25.5.2014-2030.2005. View

18.

Ou H, Lohr F, Vogel V, Mantele W, Dotsch V . Structural evolution of C-terminal domains in the p53 family. EMBO J. 2007; 26(14):3463-73. PMC: 1933395. DOI: 10.1038/sj.emboj.7601764. View

19.

Krummel K, Lee C, Toledo F, Wahl G . The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci U S A. 2005; 102(29):10188-93. PMC: 1177381. DOI: 10.1073/pnas.0503068102. View

20.

Hupp T, Lane D . Allosteric activation of latent p53 tetramers. Curr Biol. 1994; 4(10):865-75. DOI: 10.1016/s0960-9822(00)00195-0. View